Literature DB >> 33496536

The Efficacy of Intraoperative Freehand Erector Spinae Plane Block in Lumbar Spondylolisthesis: A Randomized Controlled Study.

Serdar Yeşiltaş1, Anas Abdallah, Ömer Uysal, Sinan Yılmaz, İrfan Çınar, Kazım Karaaslan.   

Abstract

STUDY
DESIGN: Prospective randomized comparative (controlled) study.
OBJECTIVE: Management of the severe postoperative back pain followed the major spinal surgeries remains a challenge. The search is going on to find simple, efficient, and reliable perioperative analgesia with low side effects. We aimed to investigate the efficacy of intraoperative freehand erector spinae plane block (ESBP) after spinal surgeries. SUMMARY OF BACKGROUND DATA: A few case reports and randomized controlled studies demonstrated the analgesic efficacy of ESPB in spinal surgeries. Up-to-date, no randomized controlled studies investigated the effectiveness of ESPB on spinal instrumentation surgeries.
METHODS: We randomly divided fifty-six consecutive adult patients who underwent posterior spinal instrumentation and fusion for spondylolisthesis into two groups. The study (ESPB) group (n = 28) received intraoperative freehand bilateral ESPB with a 20 ml mixture solution of 0.25% bupivacaine and 1.0% lidocaine equally divided into all operating levels. In the control group (n = 28), 20 ml physiological saline was injected. Postoperatively, we ordered 1 gr Paracetamol thrice/day, besides patient-controlled analgesia pumps with morphine. We performed a postoperative evaluation with a visual analog scale (VAS), morphine consumption, ESPB-related adverse effects, and postoperative length of hospital stay (PLOS).
RESULTS: Morphine consumption was significantly higher in the controls within the first postoperative 24-hour 44.75 ± 12.3 mg versus 33.75 ± 6.81 mg in the ESPB participants (p < 0.001). Except for postoperative 24th-hour VAS (p = 0.127), all postoperative VAS scores recorded at all time-points were significantly higher in the controls (p < 0.05). In control individuals, the first analgesic demand time was shorter, and PLOS was longer (p < 0.001). Patient satisfaction was significantly higher in the ESPB group. We observed no significant difference regarding postoperative complications.
CONCLUSIONS: Intraoperative ESPB as a part of multimodal analgesia was effective. For posterior instrumented patients with spondylolisthesis, it can relieve postoperative backache and reduce opioid consumption.Level of Evidence: 1.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Year:  2021        PMID: 33496536     DOI: 10.1097/BRS.0000000000003966

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  5 in total

1.  Ultrasound-Guided Erector Spinae Plane Block in Thoracolumbar Spinal Surgery: A Systematic Review and Meta-Analysis.

Authors:  Dmitriy Viderman; Mina Aubakirova; Yerlan Umbetzhanov; Gulnara Kulkaeva; S B Shalekenov; Yerkin G Abdildin
Journal:  Front Med (Lausanne)       Date:  2022-07-04

2.  Erector spinae plane block for spinal surgery: a systematic review and meta-analysis.

Authors:  Xiao Liang; Weilong Zhou; Yuchao Fan
Journal:  Korean J Pain       Date:  2021-10-01

Review 3.  The Effect of Single-Shot Erector Spinae Plane Block (ESPB) on Opioid Consumption for Various Surgeries: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Yu Cui; Yu Wang; Jing Yang; Longqing Ran; Qianqian Zhang; Qinghua Huang; Tianqing Gong; Rong Cao; Xiao Yang
Journal:  J Pain Res       Date:  2022-03-06       Impact factor: 3.133

4.  Efficacy of Erector Spinae Nerve Block for Pain Control After Spinal Surgeries: An Updated Systematic Review and Meta-Analysis.

Authors:  Mingda Duan; Yuhai Xu; Qiang Fu
Journal:  Front Surg       Date:  2022-02-28

Review 5.  Efficacy of Postoperative Analgesia by Erector Spinal Plane Block after Lumbar Surgery: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Authors:  Xiao Xiao; Tingting Zhu; Lin Wang; Hongmei Zhou; Yanli Zhang
Journal:  Comput Math Methods Med       Date:  2022-08-11       Impact factor: 2.809

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.